Cycclone Stock Price, News & Analysis
Company Description
Cycclone (OTC: CDBT) is a publicly traded pharmacies and drug stores company in the Retail Trade sector.
CDBT stock has gained 106.9% over the past year. Shares last traded at $0.0600.
This page provides a comprehensive overview of CDBT stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Cycclone (CDBT) stock last traded at $0.0600. Over the past 12 months, the stock has gained 106.9%.
Latest News
Cycclone has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 1 with negative movement. Key topics include dividends, acquisition. View all CDBT news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Cycclone (CDBT) currently stands at 63 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Cycclone (CDBT) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
CDBT Company Profile & Sector Positioning
Cycclone (CDBT) operates in the Pharmacies and Drug Stores industry within the broader Retail Trade sector and is listed on the OTC.